Clinical Trial Update: Purified Anthocyanin and Nonalcoholic Fatty Liver Disease [EARLY_Phase 1]

View source ↗

Summary

The update indicates a Phase 1 study of purified anthocyanin for nonalcoholic fatty liver disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Purified Anthocyanin

Snippet

Sponsor: Shaoguan University | Conditions: Nonalcoholic Fatty Liver Disease | EARLY_Phase 1 | Status: COMPLETED